Curis (CRIS)

• Market cap: $15.1M
• 1 day: 1.85%
• 5 days: 0%
• 1 month: 19.57%
• 3 months: -2.65%
• 6 months: -33.33%
• Year to date: 11.9%
• 1 year: -63.46%
• 5 years: -99.44%
• 10 years: -99.25%
• Sector: Healthcare
• Industry: Biotechnology

About: Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Employees: 33